aneurysm patients
clinical validation plan
individual risk of aortic rupture
clinical contact
validation initiative
formation of aortic aneurysms
aortic expansion rate
common aortic disease
clinical benefit
A4clinics software
product commercialization
targeted validation strategy
retrospective validation studies
maximum transverse aortic diameter
Biomechancial Aneurysm Risk Assessment Trial
detailed biomechanical rupture risk assessment
system large prospective validation
prioritizing patients
Expensive aneurysm repair interventions
year
effective network of clinical partners
national contact points
health care resources
product distribution plans
future health care environment
oversimplified criteria
Key points
Stockholm area screens
successful large-scale commercialization
Karolinska University Hospital
awareness
links
installation
European countries
definition
patient-specific
treatment indication
Sweden
collaboration
reason
order
contrast VASCOPS
addition early measures
market volume
diagnostic information
prevalence
proposal
Technology Readiness Level
clinicians
population
age
aim
planning